New Brain-Zapping therapy aims to boost recovery after severe head trauma
NCT ID NCT07373366
First seen Jan 29, 2026 · Last updated Jun 17, 2026 · Updated 28 times
Summary
This study tests a noninvasive treatment called REAC that uses gentle electrical signals to help rebalance brain activity after a severe traumatic brain injury. Researchers will compare real REAC sessions to a sham (fake) version in 60 patients to see if it improves brain wave patterns and daily function. The goal is to ease symptoms and support recovery, not to cure the injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital das Clínicas da FM-USP
RECRUITINGSão Paulo, São Paulo, 05.403-905, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.